NCT05002556 AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
| NCT ID | NCT05002556 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Francaise d'Urologie |
| Condition | Non-Muscle-Invasive Bladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2023-02-21 |
| Primary Completion | 2034-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2023-02-21 with a primary completion date of 2034-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain representative data, all urologists who are members of the AFU may be invited to include their patients.
Eligibility Criteria
Inclusion Criteria: * Patient being monitored for a non-muscle-invasive bladder tumor and having undergone a urinary test (biomarker) prior to their resection (biopsy) diagnosis or recurrence, * AND adult (equal to or \> 18 years old), * AND affiliated with a social security scheme in France, * AND whose monitoring will be carried out at the recruiting center. Exclusion Criteria: * Patient being monitored for a non-urothelial bladder tumor * Patient refusing follow-up * Opposition to participation in the study * Adult protected by law
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05002556 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-Muscle-Invasive Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05002556 currently recruiting?
Yes, NCT05002556 is actively recruiting participants. Contact the research team at registres@afu.fr for enrollment information.
Where is the NCT05002556 trial being conducted?
This trial is being conducted at Aix-en-Provence, France, Angers, France, Arras, France, Aubergenville, France and 11 additional locations.
Who is sponsoring the NCT05002556 clinical trial?
NCT05002556 is sponsored by Association Francaise d'Urologie. The trial plans to enroll 8,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.